Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Faying Fang, Weizhi Xu, Jian Zhang, Jin Gu & Gaoyi Yang. (2022) Ultrasound microbubble-mediated RNA interference targeting WNT1 inducible signaling pathway protein 1(WISP1) suppresses the proliferation and metastasis of breast cancer cells. Bioengineered 13:4, pages 11050-11060.
Read now
Read now
Maryam Abbaspour & Vajihe Akbari. (2022) Cancer vaccines as a targeted immunotherapy approach for breast cancer: an update of clinical evidence. Expert Review of Vaccines 21:3, pages 337-353.
Read now
Read now
Articles from other publishers (28)
Sarmistha Das & Deo Kumar Srivastava. (2023) ioSearch: An approach for identifying interacting multiomics biomarkers using a novel algorithm with application on breast cancer data sets. Genetic Epidemiology 47:8, pages 600-616.
Crossref
Crossref
Panoraia Siafaka, Emre Şefik Çağlar, Evren Atlıhan Gündoğdu & Neslihan Üstündağ Okur. (2023) New Era on Combining Both Imaging and Drug Delivery to Treat Cancer. Current Pharmaceutical Biotechnology 24:7, pages 832-855.
Crossref
Crossref
Yogita Chhichholiya, Harsh Vikram Singh, Sandeep Singh & Anjana Munshi. (2023) Genetic variations in tumor-suppressor miRNA-encoding genes and their target genes: focus on breast cancer development and possible therapeutic strategies. Clinical and Translational Oncology.
Crossref
Crossref
Vaishali Kilor, Vipin Dhote, Nidhi Sapkal & Shagufta Khan. 2023. Nanotechnology Principles in Drug Targeting and Diagnosis. Nanotechnology Principles in Drug Targeting and Diagnosis
145
172
.
Chunyan Liu, Wenli Zhao, Ligang Zhang, Huamin Sun, Xi Chen & Ning Deng. (2022) Preparation of DSPE-PEG-cRGD Modified Cationic Liposomes for Delivery of OC-2 shRNA and The Antitumor Effects on Breast Cancer. Pharmaceutics 14:10, pages 2157.
Crossref
Crossref
Sumel Ashique, Basmah Almohaywi, Nazima Haider, Sabina Yasmin, Afzal Hussain, Neeraj Mishra & Ashish Garg. (2022) siRNA-based nanocarriers for targeted drug delivery to control breast cancer. Advances in Cancer Biology - Metastasis 4, pages 100047.
Crossref
Crossref
Niloufar Tavakoli Dastjerd, Ali Valibeik, Sobhan Rahimi Monfared, Golnaz Goodarzi, Mostafa Moradi Sarabi, Faezeh Hajabdollahi, Mahmood Maniati, Jamal Amri & Sadra Samavarchi Tehrani. (2021) Gene therapy: A promising approach for breast cancer treatment. Cell Biochemistry and Function 40:1, pages 28-48.
Crossref
Crossref
Yuxia Tang, Xiang Liao, Chunyan Wang, Ying Liu, Jing Pan, Ying Tian, Zhaogang Teng & Guangming Lu. (2021) Self-assembled small messenger RNA nanospheres for efficient therapeutic apoptin expression and synergistic Gene-Chemotherapy of breast cancer. Journal of Colloid and Interface Science 603, pages 191-198.
Crossref
Crossref
Andreia Granja, Marina Pinheiro, Célia T. Sousa & Salette Reis. (2021) Gold nanostructures as mediators of hyperthermia therapies in breast cancer. Biochemical Pharmacology 190, pages 114639.
Crossref
Crossref
Biyao Yang, Bo-ping Song, Shaina Shankar, Anna Guller & Wei Deng. (2021) Recent advances in liposome formulations for breast cancer therapeutics. Cellular and Molecular Life Sciences 78:13, pages 5225-5243.
Crossref
Crossref
Hanyi Fang, Alessandra Cavaliere, Ziqi Li, Yiyun Huang & Bernadette Marquez-Nostra. (2021) Preclinical Advances in Theranostics for the Different Molecular Subtypes of Breast Cancer. Frontiers in Pharmacology 12.
Crossref
Crossref
Zhili Tian, Guohui Liang, Kunli Cui, Yayu Liang, Qun Wang, Shuangyu Lv, Xiaoxia Cheng & Lei Zhang. (2021) Insight Into the Prospects for RNAi Therapy of Cancer. Frontiers in Pharmacology 12.
Crossref
Crossref
Kewal K. JainKewal K. Jain. 2021. Textbook of Personalized Medicine. Textbook of Personalized Medicine
509
602
.
Verona Buocikova, Ivan Rios-Mondragon, Eleftherios Pilalis, Aristotelis Chatziioannou, Svetlana Miklikova, Michal Mego, Karlis Pajuste, Martins Rucins, Naouale El Yamani, Eleonora Marta Longhin, Arkadij Sobolev, Muriel Freixanet, Victor Puntes, Aiva Plotniece, Maria Dusinska, Mihaela Roxana Cimpan, Alena Gabelova & Bozena Smolkova. (2020) Epigenetics in Breast Cancer Therapy—New Strategies and Future Nanomedicine Perspectives. Cancers 12:12, pages 3622.
Crossref
Crossref
Siddhanth Hejmady, Rajesh Pradhan, Amit Alexander, Mukta Agrawal, Gautam Singhvi, Bapi Gorain, Sanjay Tiwari, Prashant Kesharwani & Sunil Kumar Dubey. (2020) Recent advances in targeted nanomedicine as promising antitumor therapeutics. Drug Discovery Today 25:12, pages 2227-2244.
Crossref
Crossref
Roja Sahu & Shakti P. Pattanayak. (2020) Strategic Developments & Future Perspective on Gene Therapy for Breast Cancer: Role of mTOR and Brk/ PTK6 as Molecular Targets. Current Gene Therapy 20:4, pages 237-258.
Crossref
Crossref
Montserrat Lara-Velazquez, Rawan Alkharboosh, Emily S. Norton, Cristopher Ramirez-Loera, William D. Freeman, Hugo Guerrero-Cazares, Antonio J. Forte, Alfredo Quiñones-Hinojosa & Rachel Sarabia-Estrada. (2020) Chitosan-Based Non-viral Gene and Drug Delivery Systems for Brain Cancer. Frontiers in Neurology 11.
Crossref
Crossref
Sadat Shafi, Sana Khan, Farazul Hoda, Faizana Fayaz, Archu Singh, Mohammad Ahmed Khan, Ruhi Ali, Faheem Hyder Pottoo, Sana Tariq & Abul Kalam Najmi. (2020) Decoding Novel Mechanisms and Emerging Therapeutic Strategies in Breast Cancer Resistance. Current Drug Metabolism 21:3, pages 199-210.
Crossref
Crossref
Xiuwei Li, Chao Ma, Huan Luo, Jian Zhang, Jinan Wang & Hongtao Guo. (2020) Identification of the differential expression of genes and upstream microRNAs in small cell lung cancer compared with normal lung based on bioinformatics analysis. Medicine 99:11, pages e19086.
Crossref
Crossref
Wei Tang, Guo-Sheng Li, Jian-Di Li, Wen-Ya Pan, Qi Shi, Dan-Dan Xiong, Chao-Hua Mo, Jing-Jing Zeng, Gang Chen, Zhen-Bo Feng, Su-Ning Huang & Min-Hua Rong. (2020) The role of upregulated miR-375 expression in breast cancer: An in vitro and in silico study. Pathology - Research and Practice 216:1, pages 152754.
Crossref
Crossref
Erez Uzuner, Yağmur Kiraz & Yusuf Baran. 2020. Biodiversity and Biomedicine. Biodiversity and Biomedicine
459
485
.
Maria Giovanna Scioli, Gabriele Storti, Federico D’Amico, Pietro Gentile, Giulia Fabbri, Valerio Cervelli & Augusto Orlandi. (2019) The Role of Breast Cancer Stem Cells as a Prognostic Marker and a Target to Improve the Efficacy of Breast Cancer Therapy. Cancers 11:7, pages 1021.
Crossref
Crossref
Xiwei Ji, Yuan Lu, Huifang Tian, Xiangrui Meng, Minji Wei & William C. Cho. (2019) Chemoresistance mechanisms of breast cancer and their countermeasures. Biomedicine & Pharmacotherapy 114, pages 108800.
Crossref
Crossref
Marta Truffi, Serena Mazzucchelli, Arianna Bonizzi, Luca Sorrentino, Raffaele Allevi, Renzo Vanna, Carlo Morasso & Fabio Corsi. (2019) Nano-Strategies to Target Breast Cancer-Associated Fibroblasts: Rearranging the Tumor Microenvironment to Achieve Antitumor Efficacy. International Journal of Molecular Sciences 20:6, pages 1263.
Crossref
Crossref
Rachel L. Mintz, Madeleine A. Gao, Kahmun Lo, Yeh-Hsing Lao, Mingqiang Li & Kam W. Leong. (2018) CRISPR Technology for Breast Cancer: Diagnostics, Modeling, and Therapy. Advanced Biosystems 2:11, pages 1800132.
Crossref
Crossref
Jun Li, Huamin Liang, Jing Liu & Ziyuan Wang. (2018) Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy. International Journal of Pharmaceutics 546:1-2, pages 215-225.
Crossref
Crossref
C Gutiérrez-Lovera, AJ Vázquez-Ríos, J Guerra-Varela, L Sánchez & M de la Fuente. (2017) The Potential of Zebrafish as a Model Organism for Improving the Translation of Genetic Anticancer Nanomedicines. Genes 8:12, pages 349.
Crossref
Crossref
Rosaria Benedetti, Carmela Dell’Aversana, Cristina Giorgio, Roberta Astorri & Lucia Altucci. (2017) Breast Cancer Vaccines: New Insights. Frontiers in Endocrinology 8.
Crossref
Crossref